ANTITHROMBOTIC DIAMINES

This application relates to the use as thrombin inhibitors, coagulation inhibitors and thromboembolic disorder agents of diamines of formula (I) as defined herein. It also provides novel compounds of formula (I), processes and intermediates for their preparation, and pharmaceutical formulations comp...

Full description

Saved in:
Bibliographic Details
Main Authors ZHANG, MINSHENG, LIN, HO-SHEN, CHIRGADZE, NICKOLAY YURI, KLIMKOWSKI, VALENTINE JOSEPH, SALL, DANIEL JON, LYNCH, MICHAEL PATRICK, KOHN, TODD JONATHAN, DENNEY, MICHAEL LYLE, PALKOWITZ, ALAN DAVID, TAKEUCHI, KUMIKO, JOHNSON, MARY GEORGE, TINSLEY, JENNIFER MARIE, FOGLESONG, ROBERT JAMES, HARPER, RICHARD WALTZ, MCCOWAN, JEFFERSON RAY, RICHETT, MICHAEL ENRICO, BASTIAN, JOLIE ANNE, SMITH, GERALD FLOYD
Format Patent
LanguageEnglish
French
Published 17.07.1997
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This application relates to the use as thrombin inhibitors, coagulation inhibitors and thromboembolic disorder agents of diamines of formula (I) as defined herein. It also provides novel compounds of formula (I), processes and intermediates for their preparation, and pharmaceutical formulations comprising the novel compounds of formula (I).
Bibliography:Application Number: CA19962236007